Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab.

Pathology - 1 Oct 2015

Williams Vaughan K, Pham Cuong, Suppiah Ram

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Blood Coagulation Factor Inhibitors
Share to Hemophilia A
Share to Immunologic Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Rituximab

Source

Identifiers

PMID: 26308136
DOI: 10.1097/PAT.0000000000000308

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab.PMID 26308136Read ↗

Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation.Semantic proximity Read ↗

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.Semantic proximity Read ↗

Key issues in inhibitor management in patients with haemophilia.Semantic proximity Read ↗

Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.Semantic proximity Read ↗

Inhibitors in haemophilia: pathophysiology.Semantic proximity Read ↗

Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.Semantic proximity Read ↗

Assessing risk factors: prevention of inhibitors in haemophilia.Semantic proximity Read ↗

Genetic risk factors for inhibitors in haemophilia A.Semantic proximity Read ↗

F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B.Semantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

Factor V deficiency: a concise review.Semantic proximity Read ↗

Inhibitors: resolving diagnostic and therapeutic dilemmas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.